Table 2.
Multivariable analysis for disease-specific and overall survival
| Variable | Disease-specific survival |
Overall survival |
||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | |
| A-XRT | ||||||
| Yes | Referent | Referent | ||||
| No | 1.9 | 1.09–3.36 | 0.02 | 1.7 | 1.01–2.92 | 0.04 |
| Pelvic ENE | ||||||
| No | Referent | Referent | ||||
| Yes | 2.0 | 1.16–3.58 | 0.01 | 2.3 | 1.37–3.99 | <0.01 |
| Chemotherapy | ||||||
| None | Referent | Referent | ||||
| Pre-op | 1.0 | 0.49–2.06 | 0.99 | 1.1 | 0.53–2.13 | 0.85 |
| post-op | 1.0 | 0.39–2.72 | 0.94 | 1.0 | 0.38–2.62 | 0.99 |
| Grade | ||||||
| 1/2 | Referent | Referent | ||||
| 3/4 | 1.2 | 0.69–2.17 | 0.49 | 1.0 | 0.59–1.79 | 0.92 |
| Treatment year | 1.0 | 0.99–1.07 | 0.13 | 1.0 | 0.99–1.06 | 0.14 |
Bold indicates significance at P < 0.05. A-XRT = adjuvant pelvic radiation therapy; HR = hazard ratio; LN = lymph nodes.